default author photo

Jiangong Zhang

Northwestern Polytechnic University (NPU)

SCHOLARLY PAPERS

2

DOWNLOADS

128

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Perioperative Toripalimab Plus Neoadjuvant Chemotherapy Improves Outcomes in Resectable Esophageal Cancer: An Interim Analysis of a Phase III Randomized Clinical Trial (HCHTOG1909)

Number of pages: 29 Posted: 31 Jul 2023
Zhengzhou University - The Affiliated Cancer Hospital, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Endoscopy Center, Zhengzhou University - Department of Endoscopy Center, Zhengzhou University - Department of Endoscopy Center, Zhengzhou University - Department of Pathology, Zhengzhou University - Department of Pathology, Zhengzhou University - Department of Radiology, Zhengzhou University - Department of Biobank, Zhengzhou University - Department of Radiology, Zhengzhou University - Department of Radiology, Zhengzhou University - Department of Thoracic Surgery, Zhengzhou University - Department of Thoracic Surgery, affiliation not provided to SSRN, Northwestern Polytechnic University (NPU) and Zhengzhou University - Department of Thoracic Surgery
Downloads 84 (777,583)
Citation 1

Abstract:

Loading...

esophageal cancer, immunochemotherapy, neoadjuvant treatment

2.

MMP-2/GSH-Responsive Nanobomb for Tumor Chemo-Immunotherapy with Hierarchical Delivery and TAMs Re-Education by Regulating Hbegf-Activated ERK/MAPK Signal Pathway

Number of pages: 40 Posted: 08 Mar 2024
Northwestern Polytechnic University (NPU), Northwestern Polytechnical University, China, Northwestern Polytechnic University (NPU), Northwestern Polytechnic University (NPU), Northwestern Polytechnic University (NPU), Northwestern Polytechnic University (NPU), Northwestern Polytechnic University (NPU), Northwestern Polytechnic University (NPU), Northwestern Polytechnic University (NPU) and Northwestern Polytechnic University (NPU)
Downloads 44 (1,133,231)

Abstract:

Loading...

immunity regulators, MMP-2/GSH-responsive, chemo-immunotherapy, Hbegf gene, ERK/MAPK signal pathway